A double-blind placebo controlled randomised trial of oral sodium clodronate [clodronic acid] for locally advanced prostatic adenocarcinoma

Trial Profile

A double-blind placebo controlled randomised trial of oral sodium clodronate [clodronic acid] for locally advanced prostatic adenocarcinoma

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Clodronic acid (Primary)
  • Indications Cancer metastases; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2009 Last checked against ISRCTN: Current Controlled Trials.
    • 01 Sep 2009 Long term overall survival results published in Lancet Oncology.
    • 18 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top